Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Jefferies Raises PT On Insulet Corporation To $20
Joe Young  
 
February 16, 2011 6:39am   Comments
Share:

Jefferies & Company has raised the price target on Insulet Corporation (NASDAQ: PODD) from $19 to $20 and maintains its Buy rating.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (PODD)

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday
Earnings Scheduled For August 7, 2025
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
Senator Mullin Discloses Stock Trades 2.5 Years After They Were Made, Including One Up 134.5%
Looking Into Insulet's Recent Short Interest
View Comments and Join the Discussion!

Posted-In: insulet corporation Jefferies & CompanyPrice Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com